Trial results for a study (NCT05144984) investigating a combination of Semaglutide and NNC0480-0389 in people with Type 2 Diabetes were posted on ClinicalTrials.gov on 2026-04-09. This update provides new information for the medical community and patients regarding potential treatment approaches for Type 2 Diabetes.
Background
The study, identified as NCT05144984, is described as "A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes." Its primary objective was to evaluate the efficacy of this specific drug combination in individuals with Type 2 Diabetes.
What this means
The availability of these trial results offers new data for clinicians, prescribers, and researchers examining combination therapies for Type 2 Diabetes. Patients and patient advocates can also review these findings to understand potential advancements in managing their condition and to inform discussions with their healthcare providers.
Source
The information regarding these trial results was sourced from ClinicalTrials.gov, a public registry and results database for clinical studies. The ClinicalTrials.gov record for study NCT05144984, titled "A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes," was updated with results on 2026-04-09.